First mass spectrometry-based test system for total 25-Hydroxyvitamin D to receive CLIA 'Moderate Complexity' designation in the U.S. Expands access to advanced testing with a fully automated, ...

FDA granted 510(k) clearance and CLIA moderate-complexity categorization approval for Focus Diagnostics’ Simplexa Flu A/B & RSV Direct test on the 3M™ Integrated Cycler. The assay, developed jointly ...

FARGO — Fargo Cass Public Health has a person certified to oversee higher level laboratory tests for patients for the first time in over a year. At the Board of Health meeting on Friday, Oct. 3, Fargo ...

An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for use on the ...

First moderate-complexity Simplexa™ assay developed through funding by U.S. Department of Health and Human Services' BARDA BAA program for public health preparedness The new test aids in the ...

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.

The assay runs on Roche's cobas® i 601 analyzer, part of the cobas® Mass Spec solution. By combining mass spectrometry's sensitivity and specificity with a standardized, easy-to-use workflow, the ...